ShadrinIY, AllenBW, QianY, et al.Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. Nat. Commun., 2017; 8: 1825. DOI: 10.1038/s41467-017-01946-x.
2.
MenascheP, VanneauxV, HagegeA, et al.Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: First clinical case report. Eur. Heart J., 2015; 36: 2011–2017. DOI: 10.1093/eurheartj/ehv189.
3.
MenascheP, VanneuaxV, HagegeA, et al.Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J. Am. Coll. Cardiol., 2018; 71. DOI: 10.1016/j.jacc.2017.11.047.
4.
GaoL, GregorichZR, ZhuW, et al.Large cardiac-muscle patches engineered from human induced-pluripotent stem-cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation, 2017; https://doi.org/10.1161/CIRCULATIONAHA.117.030785.
5.
ZhuW, ZhaoM, MattapallyS, et al.CCND2 over-expression enhances the regenerative potency of human induced pluripotent stem cell-derived cardiomyocytes: Remuscularization of injured ventricle. Circ. Res., 2018; 122: 88–96. DOI: 10.1161/CIRCRESAHA.117.311504.
ZhangJ, HuZQ, TurnerNJ, et al.Perfusion-decellularized skeletal muscle as a three-dimensional scaffold with a vascular network template. Biomaterials, 2016; 89: 114–26. https://doi.org/10.1016/j.biomaterials.2016.02.040.
